High-dose chemotherapy in breast cancer: Dutch randomized studies

nork Rodenhuis, S, van Tinteren, H, de Vries, EGE
Argitaratua 2001

Adjuvant treatment in colorectal cancer

nork Taal, B G, van Tinteren, H, van t Veer, L
Argitaratua 2002

Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III

nork Taal, B G, Van Tinteren, H, Zoetmulder, F A N
Argitaratua 2001

First-line tyrosine kinase inhibitors in EGFR mutation-positive non-small-cell lung cancer: a network meta-analysis

nork Holleman MS, van Tinteren H, Groen HJM, Al MJ, Uyl-de Groot CA
Argitaratua 2019-02-01

A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer.

nork Michalides, R., Hageman, P., van Tinteren, H., Houben, L., Wientjens, E., Klompmaker, R., Peterse, J.
Argitaratua 1996

Prospective use of serial questionnaires to evaluate the therapeutic efficacy of (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) in suspected lung cancer

nork Herder, G, van Tinteren, H, Comans, E, Hoekstra, O, Teule, G, Postmus, P, Joshi, U, Smit, E
Argitaratua 2003

Cyclin A is a prognostic indicator in early stage breast cancer with and without tamoxifen treatment

nork Michalides, R, van Tinteren, H, Balkenende, A, Vermorken, J B, Benraadt, J, Huldij, J, van Diest, P
Argitaratua 2002

Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option

nork Meulendijks, D, Dewit, L, Tomasoa, N B, van Tinteren, H, Beijnen, J H, Schellens, J H M, Cats, A
Argitaratua izan da Br J Cancer (2014)

Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology.

nork Huijgens, P C, Simoons-Smit, A M, van Loenen, A C, Prooy, E, van Tinteren, H, Ossenkoppele, G J, Jonkhoff, A R
Argitaratua 1999

Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study

nork Baas, P, Belderbos, J S A, Senan, S, Kwa, H B, van Bochove, A, van Tinteren, H, Burgers, J A, van Meerbeeck, J P
Argitaratua 2006

Effects of interleukin-3 on myelosuppression induced by chemotherapy for ovarian cancer and small cell undifferentiated tumours.

nork Dercksen, M. W., Hoekman, K., ten Bokkel Huinink, W. W., Rankin, E. M., Dubbelman, R., van Tinteren, H., Wagstaff, J., Pinedo, H. M.
Argitaratua 1993

Long-term impact of the 70-gene signature on breast cancer outcome

nork Drukker, C. A., van Tinteren, H., Schmidt, M. K., Rutgers, E. J. Th., Bernards, R., van de Vijver, M. J., van’t Veer, L. J.
Argitaratua 2014

Soluble epidermal growth factor receptor (sEGFR) and carcinoembryonic antigen (CEA) concentration in patients with non-small cell lung cancer: correlation with survival after erlot...

nork Kappers, I, Vollebergh, M A, van Tinteren, H, Korse, C M, Nieuwenhuis, L L, Bonfrer, J M G, Klomp, H M, van Zandwijk, N, van den Heuvel, M M
Argitaratua 2010

The Breast Imaging Reporting and Data System (BI-RADS) in the Dutch breast cancer screening programme: its role as an assessment and stratification tool

nork Timmers, J. M. H., van Doorne-Nagtegaal, H. J., Zonderland, H. M., van Tinteren, H., Visser, O., Verbeek, A. L. M., den Heeten, G. J., Broeders, M. J. M.
Argitaratua 2012

Differential prognostic impact of hypoxia induced and diffuse HIF-1α expression in invasive breast cancer

nork Vleugel, M M, Greijer, A E, Shvarts, A, van der Groep, P, van Berkel, M, Aarbodem, Y, van Tinteren, H, Harris, A L, van Diest, P J, van der Wall, E
Argitaratua 2005

A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study

nork Drukker, CA, Bueno-de-Mesquita, JM, Retèl, VP, van Harten, WH, van Tinteren, H, Wesseling, J, Roumen, RMH, Knauer, M, van 't Veer, LJ, Sonke, GS, Rutgers, EJT, van de Vijver, MJ, Linn, SC
Argitaratua 2013

Treatment and outcome of patients with relapsed clear cell sarcoma of the kidney: a combined SIOP and AIEOP study

nork Gooskens, S L, Furtwängler, R, Spreafico, F, van Tinteren, H, de Kraker, J, Vujanic, G M, Leuschner, I, Coulomb-L'Herminé, A, Godzinski, J, Schleiermacher, G, Stoneham, S, Bergeron, C, Pritchard-Jones, K, Graf, N, van den Heuvel-Eibrink, M M
Argitaratua 2014

Prognostic significance of age in 5631 patients with Wilms tumour prospectively registered in International Society of Paediatric Oncology (SIOP) 93-01 and 2001

nork Hol, J. A., Lopez-Yurda, M. I., Van Tinteren, H., Van Grotel, M., Godzinski, J., Vujanic, G., Oldenburger, F., De Camargo, B., Ramírez-Villar, G. L., Bergeron, C., Pritchard-Jones, K., Graf, N., Van den Heuvel-Eibrink, M. M.
Argitaratua izan da PLoS One (2019)

Molecular subtypes of breast cancer and amplification of topoisomerase IIα: predictive role in dose intensive adjuvant chemotherapy

nork Hannemann, J, Kristel, P, van Tinteren, H, Bontenbal, M, van Hoesel, Q G C M, Smit, W M, Nooij, M A, Voest, E E, van der Wall, E, Hupperets, P, de Vries, E G E, Rodenhuis, S, van de Vijver, M J
Argitaratua 2006

A randomized phase III study comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly patients with metastatic breast cancer: results of th...

nork Smorenburg, C. H., de Groot, S. M., van Leeuwen-Stok, A. E., Hamaker, M. E., Wymenga, A. N., de Graaf, H., de Jongh, F. E., Braun, J. J., Los, M., Maartense, E., van Tinteren, H., Nortier, J. W. R., Seynaeve, C.
Argitaratua izan da Ann Oncol (2014)